Updated: February 15, 2026
Quillivant XR Shortage Update: What Patients Need to Know in 2026
Author
Peter Daggett

Summarize with AI
Get the latest on the Quillivant XR shortage in 2026. Learn what's causing it, whether it's still going on, and how to find your medication.
The Quillivant XR Shortage: Where Things Stand in 2026
If you've been affected by the Quillivant XR shortage, you're not imagining things — and it's not over yet. Since 2023, patients and caregivers across the United States have struggled to find this essential ADHD medication at their pharmacies.
In this update, we'll cover the current status of the shortage, what's behind it, how much Quillivant XR costs in 2026, and the best strategies for finding it in stock.
Is Quillivant XR Still in Shortage?
Yes. As of early 2026, Quillivant XR remains listed on the FDA's drug shortage database and the ASHP (American Society of Health-System Pharmacists) shortage list. While supply has improved somewhat from the worst periods in 2023 and 2024, availability is still inconsistent across the country.
Some pharmacies may have intermittent stock, while others report being unable to order it at all. The situation varies significantly by region and by pharmacy wholesaler.
Why Is Quillivant XR Hard to Find?
The Quillivant XR shortage is driven by several overlapping factors:
Manufacturing Issues
Quillivant XR is produced exclusively by Tris Pharma in New Jersey. As a specialty liquid formulation, it requires a complex reconstitution process and specialized manufacturing. When Tris Pharma experienced production disruptions, the entire national supply was affected because there's no other manufacturer making this product.
The Broader Stimulant Shortage
The ADHD stimulant shortage that started with Adderall in late 2022 created a domino effect across the entire market. As patients switched from amphetamine-based products to methylphenidate-based ones, demand for drugs like Quillivant XR, Concerta, and Ritalin surged beyond supply capacity.
DEA Quota Restrictions
As a Schedule II controlled substance, methylphenidate production is subject to DEA manufacturing quotas. These quotas limit how much raw methylphenidate can be produced annually, making it difficult for manufacturers to quickly scale up during periods of high demand.
No Generic Competition
There is no generic version of Quillivant XR available in pharmacies as of 2026. Without generic manufacturers producing the same product, the supply depends entirely on a single manufacturer.
How Much Does Quillivant XR Cost in 2026?
The cost of Quillivant XR without insurance ranges from approximately $328 to $480 per bottle (120 mL), depending on the pharmacy.
Here are some ways to reduce costs:
- Tris Pharma Savings Card: Eligible commercially insured and cash-paying patients may pay as little as $20 per prescription. Activate at trissavingscard.com.
- GoodRx: Coupons can bring the price down to around $328 at certain pharmacies.
- SingleCare: Reports an average cash price of about $480, with potential discounts through their coupon program.
For a detailed breakdown of savings options, see our guide on how to save money on Quillivant XR.
Are There New Options for Patients in 2026?
While there haven't been new liquid methylphenidate products approved recently, patients do have some options that may not have been available or considered previously:
- QuilliChew ER — Made by the same manufacturer (Tris Pharma), this is a chewable extended-release methylphenidate tablet. It's a good option for children who can't swallow pills but don't strictly need a liquid.
- Ritalin LA sprinkle capsules — These capsules can be opened and the beads sprinkled on soft food like applesauce, offering another alternative for children who struggle with tablets.
- Dyanavel XR — A liquid extended-release stimulant, but amphetamine-based rather than methylphenidate-based. Also made by Tris Pharma.
Discuss these options with your prescriber, especially if the shortage continues. You can read more in our alternatives guide.
How to Find Quillivant XR in Stock
Even during a shortage, Quillivant XR does become available at pharmacies periodically. Here's how to maximize your chances:
- Use Medfinder to search for real-time pharmacy availability near you. This is the fastest way to find out which pharmacies have it without making dozens of phone calls.
- Try independent pharmacies. They often have different wholesaler relationships and may be able to source it when chain pharmacies can't.
- Ask your pharmacy to order it. Some pharmacies can request it directly from their distributor. Get an estimated timeline.
- Refill early. Don't wait until your bottle runs out. Start looking a few days before you need your refill.
- Set up alerts. Use Medfinder or your pharmacy's notification system to be alerted when Quillivant XR comes back in stock.
For more detailed strategies, read our post on how to find Quillivant XR in stock near you.
Final Thoughts
The Quillivant XR shortage has been one of the most persistent challenges in the broader ADHD medication supply crisis. In 2026, the medication is still in shortage, still expensive without help, and still the only long-acting liquid methylphenidate on the market.
But there are tools and strategies that can help. Medfinder puts real-time pharmacy data at your fingertips, savings programs can dramatically reduce costs, and your prescriber can guide you through alternatives if needed.
Stay informed. For more, visit our posts on why Quillivant XR is hard to find and what Quillivant XR is and how it works.
Frequently Asked Questions
No. As of early 2026, Quillivant XR remains listed as "currently in shortage" by the FDA. Supply has improved somewhat since 2023, but availability is still inconsistent across the country.
There is no confirmed date for when Quillivant XR will return to full availability. Recovery depends on Tris Pharma's manufacturing capacity, DEA quota adjustments, and overall demand for methylphenidate products. Check Medfinder for the most current pharmacy availability.
It depends. Some mail-order pharmacies carry Quillivant XR, but availability is affected by the same shortage issues. Additionally, because Quillivant XR is a Schedule II controlled substance, mail-order regulations vary by state. Check with your insurance plan's preferred mail-order pharmacy.
Yes, they're connected. The Adderall shortage that began in late 2022 caused many patients to switch to methylphenidate-based medications, increasing demand for products like Quillivant XR, Concerta, and Ritalin. This increased demand contributed to methylphenidate supply shortages.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Quillivant XR also looked for:
More about Quillivant XR
28,920 have already found their meds with Medfinder.
Start your search today.





